| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |